• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者下肢严重缺血的治疗。

Treatment for critical lower limb ischemia in elderly patients.

机构信息

Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands.

出版信息

World J Surg. 2012 Dec;36(12):2937-43. doi: 10.1007/s00268-012-1758-y.

DOI:10.1007/s00268-012-1758-y
PMID:22965534
Abstract

BACKGROUND

Critical limb ischemia (CLI) has a poor outcome when left untreated. The benefits of revascularization in the very elderly might be limited because of co-morbidities and short life expectancy. Therefore, optimal management of CLI in the elderly is not straightforward. We analyzed treatment results for elderly patients with CLI (Rutherford 4 or 5/6) in our clinic.

METHODS

Hospital charts of all patients>70 years of age diagnosed with Rutherford stage 4-6 peripheral arterial disease between January 2006 and December 2009 were reviewed. We divided patients into two age groups (70-79 and ≥80 years) to compare treatment results. Primary interventions were defined as conservative, endovascular, reconstructive surgery, and amputation. Outcome measures were mortality, reintervention, and major amputation rates.

RESULTS

There were 191 patients [99 (52%) were women], median age 78.4 years, range 70-98 years. Altogether, 119 (62%) patients were aged 70-79 years, and 72 (38%) were ≥80 years. The primary intervention was equally divided over the two age groups (p=0.21). Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC II) classifications of aortoiliac lesions were not significantly different regarding intervention (p=0.62) or age (p=0.39). TASC II classification of femoropopliteal lesions was significantly different relative to intervention (p<0.01) but not different between age groups (p=0.68). Mortality rate after reconstructive surgery was significant higher in the oldest age group (p<0.01). After conservative treatment, endovascular treatment, or amputation, the mortality rates were not significantly different between the two age groups (respectively, p=0.06, p=0.33, p=0.76). Reintervention rate was 51% in the 70- to 79-year group compared to 32% in the ≥80-year group. After initial treatment, major amputations were performed in 10% in the 70- to 79-year group compared to 13% in the ≥80-year group.

CONCLUSIONS

In patients aged≥80 years, surgical revascularization resulted in a significant higher mortality rate in our clinic, whereas primary conservative, endovascular treatment and amputation resulted in similar mortality in both age groups. When considering surgical revascularization in the very elderly, surgeons should focus on careful patient selection.

摘要

背景

未治疗的严重肢体缺血(CLI)预后不良。由于合并症和预期寿命短,非常老年患者的血运重建获益可能有限。因此,老年人 CLI 的最佳治疗并不简单。我们分析了我院 CLI(Rutherford 4 或 5/6)老年患者的治疗结果。

方法

回顾 2006 年 1 月至 2009 年 12 月期间诊断为 Rutherford 4-6 期外周动脉疾病的所有>70 岁患者的住院病历。我们将患者分为两个年龄组(70-79 岁和≥80 岁)以比较治疗结果。主要干预措施定义为保守治疗、血管内治疗、重建手术和截肢。主要终点为死亡率、再干预和大截肢率。

结果

共 191 例患者(99 例[52%]为女性),中位年龄 78.4 岁,范围 70-98 岁。共有 119 例(62%)患者年龄在 70-79 岁,72 例(38%)患者年龄≥80 岁。两个年龄组的主要干预措施基本相同(p=0.21)。在 TASC II 分类的腹主动脉髂动脉病变方面,干预方式(p=0.62)和年龄(p=0.39)无显著差异。在 TASC II 分类的股腘动脉病变方面,干预方式差异显著(p<0.01),但年龄组间无差异(p=0.68)。在最年长的年龄组中,重建手术后的死亡率明显更高(p<0.01)。在保守治疗、血管内治疗或截肢后,两个年龄组的死亡率无显著差异(分别为 p=0.06、p=0.33、p=0.76)。70-79 岁组的再干预率为 51%,而≥80 岁组为 32%。初始治疗后,70-79 岁组有 10%的患者进行了大截肢,而≥80 岁组有 13%的患者进行了大截肢。

结论

在我院,≥80 岁的患者行手术血运重建后死亡率明显更高,而保守、血管内治疗和截肢治疗在两个年龄组中的死亡率相似。在考虑对非常老年患者进行手术血运重建时,外科医生应注重仔细选择患者。

相似文献

1
Treatment for critical lower limb ischemia in elderly patients.老年患者下肢严重缺血的治疗。
World J Surg. 2012 Dec;36(12):2937-43. doi: 10.1007/s00268-012-1758-y.
2
Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization.下肢缺血的股总动脉内膜切除术:评估额外进行远端肢体血运重建的必要性。
Ann Vasc Surg. 2012 Oct;26(7):946-56. doi: 10.1016/j.avsg.2012.02.014.
3
Life Expectancy and Outcome of Different Treatment Strategies for Critical Limb Ischemia in the Elderly Patients.老年患者严重肢体缺血不同治疗策略的预期寿命及结果
Ann Vasc Surg. 2018 Jan;46:241-248. doi: 10.1016/j.avsg.2017.06.141. Epub 2017 Jul 6.
4
Impact of endovascular options on lower extremity revascularization in young patients.腔内治疗方案对年轻患者下肢血运重建的影响。
J Vasc Surg. 2012 Sep;56(3):703-13.e1-3. doi: 10.1016/j.jvs.2012.01.073. Epub 2012 May 10.
5
Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.严重肢体缺血的现实生活中血管内治疗成本:来自波兰——一个拥有低预算医疗保健系统的欧盟国家的报告。
Ann Vasc Surg. 2016 Feb;31:111-23. doi: 10.1016/j.avsg.2015.08.016. Epub 2015 Nov 23.
6
Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.腔内治疗 TASC II D 型股腘动脉病变在伴有严重肢体缺血的患者。
J Vasc Surg. 2019 May;69(5):1510-1518. doi: 10.1016/j.jvs.2018.08.176. Epub 2019 Jan 2.
7
Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.慢性肢体威胁性缺血患者股腘病变开放和血管内再通后免于截肢的生存率、肢体症状缓解率和再介入率。
J Vasc Surg. 2020 Dec;72(6):1987-1995. doi: 10.1016/j.jvs.2020.03.029. Epub 2020 Apr 8.
8
Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices.在接受血管内股腘动脉介入治疗的患者中,有无栓塞保护装置的情况下栓塞事件的临床意义。
J Vasc Surg. 2014 Feb;59(2):359-367.e1. doi: 10.1016/j.jvs.2013.07.119.
9
Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.糖尿病患者和非糖尿病患者下肢血管腔内血运重建后的主要肢体结局
J Endovasc Ther. 2017 Jun;24(3):376-382. doi: 10.1177/1526602817705135. Epub 2017 Apr 25.
10
Impact of severe chronic kidney disease on outcomes of infrainguinal peripheral arterial intervention.严重慢性肾脏病对下肢动脉血管腔内介入治疗结局的影响。
J Vasc Surg. 2014 Feb;59(2):368-75. doi: 10.1016/j.jvs.2013.09.006. Epub 2013 Oct 28.

引用本文的文献

1
Critical Limb Ischaemia in Octogenarians: Treatment Outcomes Compared With Younger Patients.老年患者的严重肢体缺血:与年轻患者相比的治疗结果
EJVES Vasc Forum. 2024 Jan 3;61:36-42. doi: 10.1016/j.ejvsvf.2023.12.003. eCollection 2024.
2
Endovascular interventions may save limbs in elderly subjects with severe lower extremity arterial disease.血管内介入治疗可能挽救患有严重下肢动脉疾病的老年患者的肢体。
J Geriatr Cardiol. 2021 Nov 28;18(11):957-967. doi: 10.11909/j.issn.1671-5411.2021.11.007.
3
Two-year Outcome of Quality of Life and Health Status for the Elderly with Chronic Limb-threatening Ischemia.

本文引用的文献

1
Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.自体大隐静脉和预袖套式ePTFE在外周动脉闭塞性疾病中的搭桥手术中期结果
Vasc Endovascular Surg. 2011 Oct;45(7):598-603. doi: 10.1177/1538574411414923. Epub 2011 Jul 14.
2
Infrainguinal percutaneous transluminal angioplasty or bypass surgery in patients aged 80 years and older with critical leg ischaemia.80 岁及以上伴有严重肢体缺血的患者行下肢经皮腔内血管成形术或旁路手术。
Br J Surg. 2011 Apr;98(4):518-26. doi: 10.1002/bjs.7390. Epub 2011 Jan 27.
3
Critical limb ischemia.
慢性肢体威胁性缺血老年人的生活质量和健康状况的两年结果。
Clin Interv Aging. 2020 Dec 22;15:2383-2395. doi: 10.2147/CIA.S272078. eCollection 2020.
4
Lower Extremity Arterial Reconstruction in Octogenarians and Older.八十岁及以上老年人的下肢动脉重建术
Ann Vasc Surg. 2016 Jul;34:171-7. doi: 10.1016/j.avsg.2015.12.024. Epub 2016 May 10.
5
Emergency surgery in the elderly: challenges and solutions.老年患者的急诊手术:挑战与解决方案
Open Access Emerg Med. 2015 Sep 8;7:55-68. doi: 10.2147/OAEM.S68324. eCollection 2015.
6
Conservative Treatment in Selected Patients with Severe Critical Limb Ischemia.部分严重肢体缺血患者的保守治疗
World J Surg. 2015 Aug;39(8):2090-5. doi: 10.1007/s00268-015-3069-6.
7
Alendronate and risk of lower limb ischemic vascular events: a population-based cohort study.阿仑膦酸盐与下肢缺血性血管事件风险:一项基于人群的队列研究。
Osteoporos Int. 2014 Feb;25(2):673-80. doi: 10.1007/s00198-013-2478-3. Epub 2013 Aug 14.
严重肢体缺血
Curr Treat Options Cardiovasc Med. 2010 Jun;12(3):214-29. doi: 10.1007/s11936-010-0076-7. Epub 2010 Apr 14.
4
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.严重肢体缺血的风险分层:使用多中心手术结果数据推导和验证预测无截肢生存期的模型。
J Vasc Surg. 2008 Dec;48(6):1464-71. doi: 10.1016/j.jvs.2008.07.062.
5
Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile.为八旬老人的慢性严重下肢缺血进行血管重建是值得的。
J Vasc Surg. 2007 Dec;46(6):1198-207. doi: 10.1016/j.jvs.2007.07.047.
6
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).外周动脉疾病管理跨学会共识(TASC II)
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67. doi: 10.1016/j.jvs.2006.12.037.
7
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia.对1404例严重肢体缺血患者下肢静脉搭桥术前和术后生活质量的前瞻性多中心研究。
J Vasc Surg. 2006 Nov;44(5):977-83; discussion 983-4. doi: 10.1016/j.jvs.2006.07.015.
8
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.PREVENT III研究结果:一项关于依地福吉德预防下肢旁路手术中静脉移植物失败的多中心随机试验
J Vasc Surg. 2006 Apr;43(4):742-751; discussion 751. doi: 10.1016/j.jvs.2005.12.058.
9
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.严重下肢缺血的搭桥术与血管成形术对比研究(BASIL):多中心随机对照试验
Lancet. 2005 Dec 3;366(9501):1925-34. doi: 10.1016/S0140-6736(05)67704-5.
10
Medical treatment of peripheral arterial disease: a comprehensive review.外周动脉疾病的医学治疗:全面综述
J Vasc Interv Radiol. 2004 Nov;15(11):1197-207. doi: 10.1097/01.RVI.0000137978.15352.C6.